[Learning disorders in neurofibromatosis type 1]
- PMID: 28256688
[Learning disorders in neurofibromatosis type 1]
Abstract
Introduction: Neurocognitive deficits and academic learning difficulties are the most common neurologic complication of neurofibromatosis type 1 (NF1) in childhood and can be responsible for significant lifetime morbidity. Children with NF1 show impairments in attention, visual perception, language, executive function, academic skills, and behavior. Studies in animal models suggest that the learning disabilities associated with NF1 are caused by excessive Ras activity that leads to increased gamma-aminobutyric acid (GABA) inhibition and to decreased long-term potentiation.
Aim: To describe the frequency, severity, typology, and natural course of specific cognitive deficits in children with NF1.
Development: Cognitive and behavioral disorders affect between 50-80% of all children with NF1. We can define three subtypes of cognitive profiles in children with NF1 and learning disorder, including global learning disorder, specific learning disorder, and isolated attention deficit hyperactivity disorder. The most common cognitive deficits are connected with visual-spatial impairment, however working memory and executive function deficits associated with prefrontal cortex dysfunction are also important.
Conclusions: There is an extremely high frequency of cognitive problems in children with NF1, making cognitive dysfunction the most common complication to affect quality of life in these children. Early diagnosis and treatment of learning disorders in these patients leads to improved academic outcome.
Title: Trastornos de aprendizaje en la neurofibromatosis tipo 1.
Introduccion. Los deficits neurocognitivos y las dificultades de aprendizaje representan las complicaciones neurologicas mas frecuentes de la neurofibromatosis tipo 1 (NF1) en la edad pediatrica y son responsables de una importante morbilidad evolutiva. Los niños con NF1 muestran alteraciones en atencion, percepcion visual, lenguaje, funciones ejecutivas, logros academicos y conducta. Los estudios en modelos animales sugieren que las alteraciones de aprendizaje en la NF1 se relacionan con una potenciacion de la actividad Ras que conduce a un incremento de la inhibicion mediada por el acido gamma-aminobutirico (GABA) y a una disminucion de la potenciacion sinaptica a largo plazo. Objetivo. Describir la frecuencia, gravedad, tipologia y evolucion natural de los deficits neurocognitivos especificos de la NF1. Desarrollo. Los trastornos neurocognitivos y conductuales afectan al 50-80% de los niños con NF1. Se pueden definir tres subtipos de perfiles cognitivos en la NF1, incluyendo trastorno de aprendizaje global, trastorno especifico de aprendizaje y trastorno por deficit de atencion/hiperactividad aislado. Los deficits cognitivos mas frecuentes se relacionan con la alteracion visuoespacial, aunque tambien son importantes las alteraciones de la memoria de trabajo y de la funcion ejecutiva asociadas con la disfuncion de la corteza prefrontal. Conclusiones. Existe una gran frecuencia global de problemas cognitivos en la NF1, lo cual implica que la disfuncion neurocognitiva sea la mayor complicacion medica que afecta la calidad de vida de estos pacientes. El diagnostico y el tratamiento precoces de los trastornos de aprendizaje en estos niños son basicos para conseguir un mejor desempeño academico.
Similar articles
-
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.Neurology. 2005 Oct 11;65(7):1037-44. doi: 10.1212/01.wnl.0000179303.72345.ce. Neurology. 2005. PMID: 16217056
-
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.Nature. 2002 Jan 31;415(6871):526-30. doi: 10.1038/nature711. Epub 2002 Jan 16. Nature. 2002. PMID: 11793011
-
[Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].Psychiatr Pol. 2005 Mar-Apr;39(2):371-81. Psychiatr Pol. 2005. PMID: 15881631 Review. Polish.
-
Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.Dev Med Child Neurol. 2006 Dec;48(12):973-7. doi: 10.1017/S0012162206002131. Dev Med Child Neurol. 2006. PMID: 17109785
-
Neurofibromatosis type 1: new insights into neurocognitive issues.Curr Neurol Neurosci Rep. 2006 Mar;6(2):136-43. doi: 10.1007/s11910-996-0036-5. Curr Neurol Neurosci Rep. 2006. PMID: 16522267 Review.
Cited by
-
Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression.Orphanet J Rare Dis. 2022 Jan 29;17(1):24. doi: 10.1186/s13023-022-02174-3. Orphanet J Rare Dis. 2022. PMID: 35093157 Free PMC article.
-
Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.Orphanet J Rare Dis. 2019 May 3;14(1):94. doi: 10.1186/s13023-019-1067-8. Orphanet J Rare Dis. 2019. PMID: 31053133 Free PMC article.
-
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.Neuro Oncol. 2020 Jun 9;22(6):773-784. doi: 10.1093/neuonc/noaa036. Neuro Oncol. 2020. PMID: 32055852 Free PMC article.
-
Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1.Genes (Basel). 2018 Apr 17;9(4):216. doi: 10.3390/genes9040216. Genes (Basel). 2018. PMID: 29673180 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous